Education
About Us
Working with TipRanks
Follow Us
CVRx (CVRX)
NASDAQ:CVRX
CVRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.30 - $18.55
Previous CloseN/A
Volume20.10K
Average Volume (3M)231.74K
Market Cap
$215.36M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Aug 04, 2025EPS Estimate
-0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.53
Shares Outstanding26,072,600
10 Day Avg. Volume382,378
30 Day Avg. Volume231,738
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$10.75Price Target Upside30.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Growth OutlookRep productivity increases, more predictable reimbursement on the horizon, and focus on top-tier accounts could return the company back to its prior longer-term growth outlook.
ReimbursementMaintaining Barostim’s current reimbursement under New Tech APC 1580 should be considered a win for CVRX.
SalesforceManagement is 'thrilled' with the experience of new reps onboarding, the majority of whom have experience in therapy development, stakeholder relationships from their prior company, and an understanding of cardiac medicine.
Bears Say
Salesforce DisruptionThe Q1 miss was attributed to the company being unable to manage the disruption from the deeper-than-expected salesforce changes.
TurnoverGreater seasonality than expected and increased turnover that was over 90% company initiated impacted results.
CVRx News
CVRX FAQ
What was CVRx’s price range in the past 12 months?
CVRx lowest stock price was $4.30 and its highest was $18.55 in the past 12 months.
What is CVRx’s market cap?
CVRx’s market cap is $215.36M.
When is CVRx’s upcoming earnings report date?
CVRx’s upcoming earnings report date is Aug 04, 2025 which is in 4 days.
How were CVRx’s earnings last quarter?
CVRx released its earnings results on May 08, 2025. The company reported -$0.53 earnings per share for the quarter, beating the consensus estimate of -$0.57 by $0.04.
Is CVRx overvalued?
According to Wall Street analysts CVRx’s price is currently Undervalued.
Does CVRx pay dividends?
CVRx does not currently pay dividends.
What is CVRx’s EPS estimate?
CVRx’s EPS estimate is -0.52.
How many shares outstanding does CVRx have?
CVRx has 26,072,600 shares outstanding.
What happened to CVRx’s price movement after its last earnings report?
CVRx reported an EPS of -$0.53 in its last earnings report, beating expectations of -$0.57. Following the earnings report the stock price went down -38.689%.
Which hedge fund is a major shareholder of CVRx?
Currently, no hedge funds are holding shares in CVRX
CVRx Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.75 (30.15% Upside)
$10.75 (30.15% Upside)
Blogger Sentiment
Bullish
CVRX Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 4.6%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.22%
12-Months-Change
Fundamentals
Return on Equity
-76.01%
Trailing 12-Months
Asset Growth
22.06%
Trailing 12-Months
Company Description
CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
CVRX Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted moderate revenue growth and promising clinical evidence supporting Barostim therapy. However, significant challenges included sales force realignment, seasonality impacts, and a decrease in sales territories, which hindered the company's short-term performance. Despite these challenges, the company remains optimistic about its strategic initiatives and long-term prospects.Read More>CVRX Stock 12 Month Forecast
Average Price Target
$10.75
▲(30.15%Upside)
Technical Analysis
Ownership Overview
11.56% Insiders
7.08% Mutual Funds
38.10% Other Institutional Investors
36.83% Public Companies and
Individual Investors